These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 19581141)
21. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071 [TBL] [Abstract][Full Text] [Related]
22. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862 [TBL] [Abstract][Full Text] [Related]
23. Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis. Tricco AC; Alateeq A; Tashkandi M; Mamdani M; Al-Omran M; Straus SE Open Med; 2012; 6(3):e109-17. PubMed ID: 23687524 [TBL] [Abstract][Full Text] [Related]
24. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. Hsu PI J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743 [TBL] [Abstract][Full Text] [Related]
25. Gastroprotective strategy in aspirin users. Luo JC J Chin Med Assoc; 2009 Jul; 72(7):343-5. PubMed ID: 19581138 [No Abstract] [Full Text] [Related]
26. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136 [TBL] [Abstract][Full Text] [Related]
27. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding. Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521 [TBL] [Abstract][Full Text] [Related]
28. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin. Takada M; Fujimoto M; Hosomi K Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400 [TBL] [Abstract][Full Text] [Related]
29. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications]. ; Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333 [TBL] [Abstract][Full Text] [Related]
30. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin. Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248 [TBL] [Abstract][Full Text] [Related]
31. The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice. Lanas A; Polo-Tomás M; Casado-Arroyo R Aliment Pharmacol Ther; 2013 Apr; 37(7):738-48. PubMed ID: 23413984 [TBL] [Abstract][Full Text] [Related]
32. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations]. Hiraishi H; Shimada T Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539 [TBL] [Abstract][Full Text] [Related]
33. Use of antiplatelet drugs in the stroke unit of a Hong Kong hospital. Luk HH; Pang J; Li LS; Ng M Pharm World Sci; 2005 Jun; 27(3):258-62. PubMed ID: 16096898 [TBL] [Abstract][Full Text] [Related]
34. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin. Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119 [TBL] [Abstract][Full Text] [Related]
35. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy. Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523 [TBL] [Abstract][Full Text] [Related]
36. Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan. Fujisawa N; Inamori M; Endo H; Uchiyama T; Hosono K; Akiyama T; Tomimoto A; Koyama S; Sawabe A; Tanida E; Yanagisawa S; Hata Y; Okada K; Atsukawa K; Watanabe S; Kawamura H; Higurashi T; Nagase H; Akimoto K; Matsuhashi N; Nakajima A Hepatogastroenterology; 2011; 58(105):229-34. PubMed ID: 21510320 [TBL] [Abstract][Full Text] [Related]
37. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study. Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193 [TBL] [Abstract][Full Text] [Related]
38. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan. Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869 [TBL] [Abstract][Full Text] [Related]
39. [Risk factors for gastrointestinal bleeding associated with low-dose aspirin]. Sibilia J; Ravaud P; Marck G Presse Med; 2003 Nov; 32(37 Pt 2):S9-16. PubMed ID: 14763349 [TBL] [Abstract][Full Text] [Related]